Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × deltacortene × 30 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 8 Prostatic Neoplasms 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Vasculitis, Central Nervous System 1 Urogenital Neoplasms 1 Stiff-Person Syndrome 1 Rasmussen subacute encephalitis 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myasthenia Gravis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Biphenotypic, Acute 1 Lambert-Eaton Myasthenic Syndrome 1 HTLV-I Infections 1 Down Syndrome 1 Colitis 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

venetoclax 61 Azacitidine 51 Cytarabine 33 Specimen Handling 28 Biopsy 21 fludarabine 19 Daunorubicin 18 Injections 17 Decitabine 16 fludarabine phosphate 13 Cyclophosphamide 13 Whole-Body Irradiation 12 CPX-351 12 Idarubicin 11 Melphalan 10 Stem Cell Transplantation 9 Busulfan 9 gilteritinib 8 decitabine and cedazuridine drug combination 8 Mycophenolic Acid 8 Granulocyte Colony-Stimulating Factor 8 Magnetic Resonance Spectroscopy 7 Liposomes 7 Filgrastim 7 ivosidenib 6 enasidenib 6 Gemtuzumab 6 revumenib 5 olutasidenib 5 Mesna 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡